Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-12-01
1990-10-23
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
540556, 544349, 546123, 546156, A61K 31435, C07D47104
Patent
active
049652737
ABSTRACT:
There are disclosed new naphthyridine- and quinoline-carboxylic acids having a 1-tertiary-alkyl substituent, compositions containing them, and their use in treating bacterial infections in warm-blooded animals. Also disclosed are novel amines and intermediates used in the preparation of the naphthyridine- and quinoline-carboxylic acids.
REFERENCES:
patent: 4284629 (1981-08-01), Grohe et al.
patent: 4571396 (1986-02-01), Hutt et al.
patent: 4705788 (1987-11-01), Schriewer et al.
patent: 4775668 (1988-10-01), Jefson et al.
Bouzard Daniel
Di Cesare Pierre
Essiz Munir
Jacquet Jean-Pierre
Remuzon Philippe
Algieri Aldo A.
Bristol-Myers Company
Dentz Bernard I.
Ford John M.
LandOfFree
Certain 1-tertiary-butyl-naphthyridone carboxylic acid derivativ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Certain 1-tertiary-butyl-naphthyridone carboxylic acid derivativ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain 1-tertiary-butyl-naphthyridone carboxylic acid derivativ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-767113